
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $175M | -- | -- | $0.63 | -- |
07/28/2025 | Q2 | $167M | -- | -- | $0.59 | -- |
04/28/2025 | Q1 | $162.8M | $166.7M | $0.56 | $0.57 | -$0.01 |
02/03/2025 | Q4 | $160.3M | $161.1M | $0.58 | $0.56 | $0.02 |
10/28/2024 | Q3 | $147.5M | $145.5M | $0.45 | $0.51 | -$0.06 |
07/29/2024 | Q2 | $139M | $132.1M | $0.33 | $0.45 | -$0.12 |
04/29/2024 | Q1 | $135.9M | $117.9M | $0.30 | $0.44 | -$0.14 |
02/05/2024 | Q4 | $135M | $122.2M | $0.53 | $0.45 | $0.08 |
10/30/2023 | Q3 | -- | -- | $0.93 | $0.41 | $0.52 |
07/31/2023 | Q2 | -- | -- | $1.51 | $0.39 | $1.12 |
05/01/2023 | Q1 | -- | -- | $0.03 | $0.42 | -$0.39 |
02/06/2023 | Q4 | -- | -- | $0.14 | $0.47 | -$0.33 |
10/31/2022 | Q3 | -- | -- | $0.01 | $0.41 | -$0.40 |
08/01/2022 | Q2 | -- | -- | $0.31 | $0.40 | -$0.09 |
05/02/2022 | Q1 | -- | -- | -$0.60 | $0.37 | -$0.97 |
02/07/2022 | Q4 | -- | -- | $0.05 | $0.37 | -$0.32 |
11/01/2021 | Q3 | -- | -- | $0.03 | $0.33 | -$0.30 |
08/02/2021 | Q2 | -- | -- | $0.10 | $0.31 | -$0.21 |
05/03/2021 | Q1 | -- | -- | -$0.02 | $0.28 | -$0.30 |
02/01/2021 | Q4 | -- | -- | -$0.11 | $0.25 | -$0.36 |
11/02/2020 | Q3 | -- | -- | -$0.11 | $0.27 | -$0.38 |
08/03/2020 | Q2 | -- | -- | -$0.09 | $0.25 | -$0.34 |
05/04/2020 | Q1 | -- | -- | -$0.07 | $0.23 | -$0.30 |
01/27/2020 | Q4 | -- | -- | -$0.09 | $0.25 | -$0.34 |
11/04/2019 | Q3 | -- | -- | -$0.16 | $0.23 | -$0.39 |
07/29/2019 | Q2 | -- | -- | -$0.33 | $0.20 | -$0.53 |
04/22/2019 | Q1 | -- | -- | -$0.24 | $0.23 | -$0.47 |
01/28/2019 | Q4 | -- | -- | -$0.02 | $0.26 | -$0.28 |
10/29/2018 | Q3 | -- | -- | -$0.97 | $0.22 | -$1.19 |
07/30/2018 | Q2 | -- | -- | -$0.14 | -- | -- |
05/07/2018 | Q1 | -- | -- | -$0.33 | -- | -- |
01/29/2018 | Q4 | -- | -- | -$0.29 | -- | -- |
10/23/2017 | Q3 | -- | -- | $0.07 | -- | -- |
07/24/2017 | Q2 | -- | -- | $0.02 | -- | -- |
04/24/2017 | Q1 | -- | -- | $0.03 | -- | -- |
01/30/2017 | Q4 | -- | -- | -$0.03 | -- | -- |
10/24/2016 | Q3 | -- | -- | $0.04 | -- | -- |
07/18/2016 | Q2 | -- | -- | $0.03 | -- | -- |
04/18/2016 | Q1 | -- | -- | $0.02 | -- | -- |
01/25/2016 | Q4 | -- | -- | $0.11 | -- | -- |
10/19/2015 | Q3 | -- | -- | $1.52 | -- | -- |
Rambus reported $166.7M worth of top line sales in its most recent quarter.
Rambus announced earnings per share of $0.56 which represents a miss of analyst forecast a $0.57 per share.
Rambus reported $133.8M that represents $1.23 per share over the last quarter.
Rambus's earnings are forecast to grow from $1.65 per share to $1.92 per share next year representing an increase of 51.21%.
Rambus's next earnings date is July 28, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.